A comparative study of the effects of imeglimin add-on or metformin dose escalation on glycaemic variability in subjects with type 2 diabetes treated with low-dose metformin (MEGMI-CGM study).
Akihiro TakahashiHiroshi NomotoKinnosuke OnishiSatoru MandaAika MiyaHiraku KamedaAkinobu NakamuraTatsuya AtsumiPublished in: Diabetes, obesity & metabolism (2024)